Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #11,551 to #11,600.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Portopulmonary hypertension CT (1 revision)
  2. Portopulmonary hypertension MRI (1 revision)
  3. Portopulmonary hypertension case study one (1 revision)
  4. Portopulmonary hypertension causes (1 revision)
  5. Portopulmonary hypertension classification (1 revision)
  6. Portopulmonary hypertension electrocardiogram (1 revision)
  7. Portopulmonary hypertension historical perspective (1 revision)
  8. Portopulmonary hypertension other imaging findings (1 revision)
  9. Portopulmonary hypertension risk factors (1 revision)
  10. Portopulmonary hypertension screening (1 revision)
  11. Portopulmonary hypertension x ray (1 revision)
  12. Posaconazole (patient information) (1 revision)
  13. Posaconazole adverse reactions (1 revision)
  14. Posaconazole clinical pharmacology (1 revision)
  15. Posaconazole contraindications (1 revision)
  16. Posaconazole description (1 revision)
  17. Posaconazole drug interactions (1 revision)
  18. Posaconazole microbiology (1 revision)
  19. Posaconazole warnings and precautions (1 revision)
  20. Position (Obstetrics) (1 revision)
  21. Position effect (1 revision)
  22. Positional plagiocephaly (1 revision)
  23. Positive and Negative Syndrome Scale (1 revision)
  24. Positive behavior support (1 revision)
  25. Positive feedback (1 revision)
  26. Positive pressure ventilation (1 revision)
  27. Positive psychology (1 revision)
  28. Positron radiation astronomy (1 revision)
  29. Positronium (1 revision)
  30. Post-Orbital Constriction (1 revision)
  31. Post-abduction syndrome (1 revision)
  32. Post-chemotherapy cognitive impairment case study one (1 revision)
  33. Post-chemotherapy cognitive impairment causes (1 revision)
  34. Post-chemotherapy cognitive impairment classification (1 revision)
  35. Post-chemotherapy cognitive impairment differential diagnosis (1 revision)
  36. Post-chemotherapy cognitive impairment epidemiology and demographics (1 revision)
  37. Post-chemotherapy cognitive impairment future or investigational therapies (1 revision)
  38. Post-chemotherapy cognitive impairment historical perspective (1 revision)
  39. Post-chemotherapy cognitive impairment history and symptoms (1 revision)
  40. Post-chemotherapy cognitive impairment laboratory findings (1 revision)
  41. Post-chemotherapy cognitive impairment natural history, complications and prognosis (1 revision)
  42. Post-chemotherapy cognitive impairment other diagnostic studies (1 revision)
  43. Post-chemotherapy cognitive impairment other imaging findings (1 revision)
  44. Post-chemotherapy cognitive impairment pathophysiology (1 revision)
  45. Post-chemotherapy cognitive impairment physical examination (1 revision)
  46. Post-chemotherapy cognitive impairment primary prevention (1 revision)
  47. Post-chemotherapy cognitive impairment risk factors (1 revision)
  48. Post-chemotherapy cognitive impairment secondary prevention (1 revision)
  49. Post-chemotherapy cognitive impairment surgery (1 revision)
  50. Post-cycle therapy (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)